Does ruxolitinib prolong the survival of patients with myelofibrosis?

Cervantes Francisco; Pereira Arturo

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Does ruxolitinib prolong the survival of patients with myelofibrosis?

【24h】

Does ruxolitinib prolong the survival of patients with myelofibrosis?

机译：芦可替尼是否能延长骨髓纤维化患者的生存期？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2017年第7期|832-837|共6页
作者
Cervantes Francisco; Pereira Arturo;
展开▼
作者单位

Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Dept Hematol, Barcelona, Spain;

Hosp Clin Barcelona, Dept Hematol, Villarroel 170, Barcelona 08036, Spain;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Combination therapy of long-term tumor treating fields with temozolomide and bevacizumab prolongs survival in multifocal glioblastoma diagnosed patient: a case report [J] . Damir Nizamutdinov, Kaiyang Feng, Amanda Johnson, 转化神经科学电子杂志（英文） . 2019,第001期
2. The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies [J] . Gupta Vikas, Harrison Claire, Hexner Elizabeth O.Al-Ali Haifa KathrinFoltz LyndaMontgomery MichaelSun WilliamGopalakrishna PrashanthKantarjian HagopVerstovsek Srdan Haematologica . 2016,第12期

机译：The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies
3. Light and shade of ruxolitinib: positive role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in patients with myelofibrosis [J] . Baek Dong Won, Cho Hee Jeong, Lee Jung MinKim JuhyungMoon Joon HoSohn Sang Kyun Expert review of hematology . 2022,第12期

机译：Light and shade of ruxolitinib: positive role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in patients with myelofibrosis
4. Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib [J] . Ayalew Tefferi, Animesh Pardanani, Kebede H. BegnaAref Al‐KaliWilliam J. HoganMark R. LitzowCurtis A. HansonRhett P. KetterlingNaseema Gangat American Journal of Hematology . 2022,第12期

机译：Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib
5. Quantitative proteomic study of the action of ruxolitinib, a potent JAK inhibitor [C] . R.L.J. Graham, A. DAmato, J.P. Lally, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：ruxolitinib的定量蛋白质组学研究，一种有效的JAK抑制剂
6. TTBK2 and Primary Cilia Are Required for Purkinje Cell Survival [D] . Bowie, Emily J. 2019

机译：Purkinje Cell Survival需要TTBK2和初级纤毛
7. Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study [O] . Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, 2020

机译：ruxolitinib和干扰素-α2组合疗法治疗多胆症Vera或myelofibrosis的患者：II期研究
8. Implication of human nonmetastatic clone 23 Type 1 and its downstream gene lipocalin 2 in metastasis and patient's survival of cancer of uterine cervix [O] . Po-Hui Wang, Shun-Fa Yang, Long-Yau Lin, 2012

机译：Implication of human nonmetastatic clone 23 Type 1 and its downstream gene lipocalin 2 in metastasis and patient's survival of cancer of uterine cervix
9. II paziente disfagico: manual per familiari e caregiver (The Dysphagic Patient: Handbook for Family and Caregivers). [R] . Gaita, A., Barba, L., Calcagno, P., 2008

机译：II paziente disfagico：手册每个家庭护理员（The Dysphagic patient：Handbook for Family and Caregivers）。

Does ruxolitinib prolong the survival of patients with myelofibrosis?

著录项

引文网络

相似文献

相关主题

期刊订阅